Cybin Inc (CYBN)
US$ 10.575.7%
Price Chart
Key Statistics
Market Cap
$ 174.86M
P/E Ratio
0.00
Revenue (TTM)
$ 0
Volume
464.79K
52W High
$ 13.88
52W Low
$ 4.81
Dividend Yield
0.00%
Beta
1.13
Technicals
50-Day MA
6.8422
200-Day MA
8.8259
52 Week High
13.88
52 Week Low
4.81
About CYBN
Cybin Inc., a clinical-stage biopharmaceutical company, focuses on developing psychedelic-based therapeutics for patients with mental health conditions.
Employees
50
Headquarters
Toronto, ON
CEO
Mr. Eric So L.L.B.
Latest News
Top Gainers
Symbol/Name
LTP
% Chg
Top Losers
Symbol/Name
LTP
% Chg